Zeo ScientifiXZEOX 50 Market Cap is $13.72 Mil as of Jun. 27, 2026. GuruFocus rates ZEOX with a GF Score™ of 50/100 and a GF Value™ of $2.67 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,431 Biotechnology companies, Zeo ScientifiX ranks worse than 81.06% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zeo ScientifiX's share price for the quarter that ended in Apr. 2026 was $1.94. Zeo ScientifiX's Shares Outstanding (EOP) for the quarter that ended in Apr. 2026 was 7.79 Mil. Therefore, Zeo ScientifiX's market cap for the quarter that ended in Apr. 2026 was $15.11 Mil.
Zeo ScientifiX's quarterly market cap
increased
from Oct. 2025 ($12.62 Mil) to Jan. 2026 ($20.30 Mil) but then
declined
from Jan. 2026 ($20.30 Mil) to Apr. 2026 ($15.11 Mil).
Zeo ScientifiX's annual market cap
declined
from Oct. 2023 ($12.89 Mil) to Oct. 2024 ($10.79 Mil) but then
increased
from Oct. 2024 ($10.79 Mil) to Oct. 2025 ($12.62 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zeo ScientifiX's Enterprise Value for Today is $12.21 Mil.
Zeo ScientifiX (OTCPK:ZEOX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Zeo ScientifiX Market Cap Related Terms
Zeo ScientifiX Market Cap Historical Data
* Premium members only.
The historical data trend for Zeo ScientifiX's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Zeo ScientifiX's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Market Cap distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Zeo ScientifiX's Market Cap for the fiscal year that ended in Oct. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX (ZEOX) has a Market Cap of $13.72 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zeo ScientifiX and its competitors. According to the industry distribution chart, Zeo ScientifiX ranks #1160 out of 1431 companies in the Biotechnology industry, placing it in the top 81.1%.
Is Zeo ScientifiX's Market Cap too high?
Zeo ScientifiX's current Market Cap is $13.72 Mil. The Biotechnology industry median Market Cap is 113.83. Zeo ScientifiX's value of $13.72 Mil is 87.9% below this industry median. Based on the distribution chart, Zeo ScientifiX ranks #1160 out of 1431 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zeo ScientifiX has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's Market Cap compare to LNAI and GDTC?
According to the Biotechnology industry distribution chart, Zeo ScientifiX ranks #1160 out of 1431 companies for Market Cap. This places Zeo ScientifiX in the lower half of its industry. The industry median Market Cap is 113.83. Zeo ScientifiX's value of $13.72 Mil is 87.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zeo ScientifiX's current Market Cap of $13.72 Mil is 87.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Zeo ScientifiX and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zeo ScientifiX's current Market Cap is $13.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Possible Value Trap. The stock's GF Value™ is $2.67, compared to a current price of $1.75 — trading 34.5% below its estimated fair value. The current Market Cap is $13.72 Mil and 87.9% below the Biotechnology industry median of 113.83. Zeo ScientifiX's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current Market Cap is $13.72 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zeo ScientifiX (ZEOX) Overvalued in 2026?
Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued.
The current stock price of $1.75 is trading 34.5% below its estimated GF Value™ of $2.67.
GuruFocus considers Zeo ScientifiX to be Possible Value Trap.
Key valuation signals for ZEOX:
Market Cap: $13.72 Mil
GF Value™: $2.67 vs. price of $1.75 (34.5% below fair value)
Industry Position: 87.9% below the Biotechnology median (#1160 of 1431)
No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
50GF Score
Get the complete analysis for ZEOX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZEOX has been successfully added to your 
